NXGLW
NEXGEL, Inc.
NASDAQ · Healthcare · Medical - Instruments & Supplies · US
$0.02
+21.48%Next report
Analyst consensus
- Next report date
- Nov 17, 2026
- EPS estimate
- -$0.24
- Revenue estimate
- $4.2M
Latest reported
- Last report date
- Aug 17, 2026
- EPS actual
- -$0.12
- EPS estimate
- -$0.12
- Revenue actual
- $4.3M
- Revenue estimate
- $4.3M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 0
- EPS misses (12Q)
- 4
- EPS in line (12Q)
- 1
- Avg surprise (4Q)
- -23.2%
- Revenue beats (12Q)
- 0
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 17, 2026 | -$0.12 | -$0.12 | In line | $4.3M |
| May 14, 2026 | -$0.07 | -$0.11 | Miss -57.14% | $2.6M |
| Mar 31, 2026 | -$0.09 | -$0.12 | Miss -33.33% | $2.8M |
| Nov 11, 2025 | -$0.08 | -$0.08 | Miss -2.40% | $2.9M |
| Aug 12, 2025 | -$0.07 | -$0.09 | Miss -24.11% | $2.9M |
| Sep 29, 2023 | — | -$0.00 | — | $1.2M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 17, 2026